See the DrugPatentWatch profile for Erythrocin
Who is the current sponsor/manufacturer of Erythrocin (erythromycin) as of 2025?
The provided information does not include the identity of Erythrocin’s 2025 “current sponsor” (for example, the listed NDA/ANDA holder, marketing authorization holder, or rights holder). Without a source that names the sponsor/manufacturer for the 2025 period, I can’t confirm it accurately.
Where to check the 2025 sponsor for Erythrocin (erythromycin)?
To find the correct current sponsor/manufacturer, the most reliable places are the product’s official regulatory and labeling records, such as:
- The drug’s U.S. FDA “Drug Label Information” page and the referenced application/holder for the specific strength and dosage form.
- The DailyMed label for the exact product/strength, which typically lists the manufacturer and sometimes the labeler (based on SPL data).
- EMA product information (if you mean an EU marketing authorization), which lists the marketing authorization holder.
Does “Erythrocin” refer to one specific product, or are there multiple labels/sponsors?
“Erythrocin” can refer to different erythromycin products (different strengths, formulations, or markets). Sponsor/manufacturer can change by:
- dosage form (tablet vs. suspension vs. ophthalmic/other),
- strength,
- country/market,
- application type (NDA vs. ANDA) and labeler.
If you share the exact label you mean (country + strength + dosage form, e.g., “Erythrocin 250 mg tablets” or “erythromycin ethylsuccinate suspension”), I can pinpoint which “sponsor” field to use and help you locate the current one for 2025.
Quick clarification request
Which market/product details do you mean for “Erythrocin”?
- Country (US, EU, UK, etc.)
- Strength and dosage form (tablets, suspension, ophthalmic, etc.)
Once you provide that, I can give the specific current sponsor/manufacturer for 2025 based on the relevant label/regulatory record.
Sources
No sources were provided in the prompt.